Your session is about to expire
← Back to Search
Group and Phone Follow-Up for Emotional Crisis
N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after discharge
Awards & highlights
Study Summary
This trial tests an intervention that could help save lives by providing a better alternative to emergency care for those with suicidal crises.
Who is the study for?
This study is for adults experiencing an emotional crisis or suicidal thoughts who are admitted to a Crisis Stabilization Center (CSC). Participants must be able to communicate in English and provide emergency contact information. It's not suitable for individuals under 18, those with acute psychiatric instability like psychosis, or anyone unable to understand the study.Check my eligibility
What is being tested?
The trial is testing 'THRIVE', a follow-up care program designed for people after they've had a suicidal crisis. It includes personalized recovery planning and phone check-ins post-discharge from CSCs. The goal is to see if this approach helps people feel better compared to usual safety planning.See study design
What are the potential side effects?
Since THRIVE involves counseling and follow-up rather than medication, there aren't typical side effects like you'd expect with drugs. However, discussing emotional crises can sometimes temporarily increase distress.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after discharge
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Perceived Burdensomeness
Thwarted Belongingness
Treatment Initiation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: THRIVE + Discharge / Safety PlanningExperimental Treatment1 Intervention
Participants assigned to the intervention condition will receive THRIVE Crisis Recovery and Care Transition Program, which consists of group-based reflections on "giving and belonging" and a plan for community connection and treatment, followed by 3-4 coaching calls to reinforce and troubleshoot the plans.
Group II: Discharge / Safety Planning AloneActive Control1 Intervention
Participants assigned to the control condition will receive Discharge/Safety Planning as it is practiced by Connections Health Solutions per industry best practices.
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
836 Previous Clinical Trials
518,006 Total Patients Enrolled
17 Trials studying Suicide
89,739 Patients Enrolled for Suicide
Centerstone Research InstituteOTHER
3 Previous Clinical Trials
1,630 Total Patients Enrolled
1 Trials studying Suicide
150 Patients Enrolled for Suicide
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot communicate in English with the researcher.I am under 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Discharge / Safety Planning Alone
- Group 2: THRIVE + Discharge / Safety Planning
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the enrollment process for this experiment still open to volunteers?
"Clinicaltrials.gov states that this research trial is no longer actively seeking new participants, having started on September 30th 2023 and last updated November 23rd 2022. However, there are presently 170 other clinical trials recruiting patients in the area."
Answered by AI
Share this study with friends
Copy Link
Messenger